1. Belknap J and Crabbe J. Chromosome mapping of gene loci affecting morphine
and amphetamine responses in BXD recombinant inbred mice. Ann NY
Acad Sci 1992; 654: 311-323.
2. Belknap J, Crabbe J, Riggan J and O'Toole L.
Voluntary consumption of morphine in 15 inbred mouse strains.
Psychopharmacology 1993; 112: 352-258.
3. Belknap J, Crabbe J and Young E. Voluntary consumption of ethanol in 15 inbred
mouse strains. Psychopharmacology 1993; 112: 503-510.
4. Belknap J, Laursen S, Sampson K and Wilkie
A. Where are the mu opioid receptors
that mediate analgesia? An autoradioagraphic
study in HAR and LAR mice. J
Addict Dis 1991; 10: 29-44.
5. Belknap J and O'Toole L. Studies of genetic differences in response
to opioid drugs. Crabbe J and Harris
R, eds. The genetic basis for alcohol and drug actions. New York: Plenum Publishing Corporation; 1991:
225-252.
6. Belknap J, Riggan J, Cross S, Young E, Gallaher
E and Crabbe J. Genetic determinants
of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol
Biochem Behav 1998; 59: 353-360.
7. Buck K, Crabbe J and Belknap J. Alcohol and other abused drugs. Pfaff D, Kaplitt M, Berrettini W, Joh T and
Maxson S, eds. Handbook of genetic influences on the nervous system. Boca Raton, FL: CRC Press; in press:
8. Buck K, Hahner L, Sikela J and Harris R.
Chronic ethanol treatment alters brain levels of g-aminobutyric acid
A receptor subunit mRNAs: relationship to genetic differences in ethanol withdrawal
seizure severity. J Neurochem
1991; 57: 1452-1455.
9. Buck K and Harris R. Chronic ethanol exposure of Xenopus oocytes expressing mouse brain
mRNA reduces GABA receptor-activated current and benzodiazepine receptor ligand
modulation. Mol Neuropharmacol 1991; 1: 59-64.
10. Buck K and Harris R. Neuroadaptive responses to chronic ethanol.
Alcohol Clin Exp Res 1991; 15: 460-470.
11. Buck K, Metten P, Belknap J and Crabbe J.
Quantitative trait loci involved in genetic predisposition to acute
alcohol withdrawal in mice. J Neurosci
1997; 17: 3946-3955.
12. Buck K, Metten P, Belknap J and Crabbe J.
Quantitative trait loci affecting risk for pentobarbital withdrawal
map near alcohol loci on mouse chromosomes 1, 4 and 11.
Submitted.
13. Caine S and Koob G. Modulation of cocaine self-administration in
the rat through D3 dopamine receptors. Science 1993; 260: 1814-1816.
14. Carr L, Foroud T, Bice P, Gobbett T, Ivashina
J, Edenberg H, Lumeng L and Li T-K. A
quantitative trait locus for alcohol consumption in selectively bred rat lines.
Alcohol Clin Exp Res 1998; 22: 884-887.
15. Carr L, Mellencamp B, Crabb D, Weiner H, Lumeng
L and Li T-K. Polymorphism of the
rat liver mitochondrial aldehyde dehydrogenase cDNA. Alcohol
Clin Exp Res 1991; 15: 753-756.
16. Chen J, Kelz M, Zeng G, Sakai N, Steffen C,
Shockett P, Picciotto M, Duman R and Nestler E. Transgenic animals with inducible, targeted gene expression in brain.
Mol Pharmacol 1998; 54: 495-503.
17. Chen W, Hardy P and Wilce P. Differential expression of mitochondrial NADH
dehydrogenase in ethanol-treated rat brain: Revealed by differential display.
Alcohol Clin Exp Res 1997; 21: 1053-1557.
18. Cloninger C. Neurogenetic adaptive mechanisms in alcoholism. Science
1987; 236: 410-416.
19. Collins A and Marks M. Genetic studies of nicotinic and muscarinic
agents. Crabbe J and Harris R, eds.
The
genetic basis for alcohol and drug actions. New York: Plenum Publishing Corporation; 1991: 323-352.
20. Copeland N, Jenkins N, Gilbert D, Eppig J,
Maltais L, Miller J, Dietrich W, Weaver A, Lincoln S, Steen R, Stein L, Nadeau
J and Lander E. A genetic linkage
map of the mouse: current applications and future prospects. Science
1993; 262: 57-66.
21. Crabbe J.
Provisional mapping of quantitative trait loci for chronic ethanol
withdrawal severity in BXD recombinant inbred mice. J Pharmacol Exp Ther 1998;
286: 263-271.
22. Crabbe J, Belknap J and Buck K. Genetic animal models of alcohol and drug abuse.
Science 1994; 264: 1715-1723.
23. Crabbe J, Gallaher E, Cross S and Belknap J.
Genetic determinants of sensitivity to diazepam in inbred mice.
Behav Neurosci 1998; 112: 668-677.
24. Crabbe J, Gallaher E, Phillips T and Belknap
J. Genetic determinants of sensitivity
to ethanol in inbred mice. Behav Neurosci 1994; 108: 186-195.
25. Crabbe J and Harris R, eds. The genetic
basis of alcohol and drug actions. New
York: Plenum; 1991.
26. Crabbe J and Li T-K. Genetic strategies in preclinical substance
abuse research. Bloom F and Kupfer
D, eds. Psychopharmacology: The fourth generation of progress. New York: Raven Press; 1995: 799-811.
27. Crabbe J, Merrill C and Belknap J. Acute dependence on depressant drugs is determined
by common genes in mice. J Pharmacol Exp Ther 1991; 257: 663-667.
28. Crabbe J and Phillips T. Genetics of alcohol and other abused drugs.
Drug Alcohol Depend 1998; 51: 61-71.
29. Crabbe J, Phillips T, Buck K, Cunningham C
and Belknap J. Identifying genes for
alcohol and drug sensitivity: Recent progress and future directions. Trends
Neurosci in press.
30.
Crabbe J, Phillips T, Cunningham C and Belknap J. Genetic determinants of ethanol reinforcement. Ann NY
Acad Sci 1992; 654: 302-310.
31. Crabbe J, Phillips T, Feller D, Hen R, Wenger
C, Lessov C and Schafer G. Elevated
alcohol consumption in null mutant mice lacking 5-HT1B receptors. Nat Gen
1996; 14: 98-101.
32. Deitrich R and Erwin V, eds. Pharmacological
effects of ethanol on the nervous system.
New York: CRC Press; 1996.
33. Deitrich R and Spuhler K. Genetics of alcoholism and alcohol actions.
Smart R, Cappell H, Glazer F et al., eds. Research advances in alcohol and drug problems. New York: Plenum Publishing Corporation; 1984:
47-98.
34. Douglass J, McKinzie A and Couceyro P. PCR differential display identifies a rat brain
mRNA which is transcriptionally regulated by cocaine and amphetamine.
J Neurosci 1995; 15: 2471-2481.
35. Erwin V and Deitrich R. Genetic selection and characterization of mouse
lines for acute functional tolerance to ethanol. J Pharmacol
Exp Ther 1996; 279: 1310-1317.
36. Erwin V, Markel P, Johnson T, Gehle V and Jones
B. Common quantitative trait loci
for alcohol-related behaviors and central nervous system neurotensin measures:
hypnotic and hypothermic effects. J Pharmacol Exp Ther 1997; 280: 911-918.
37. Erwin V, McClearn G and Kuse A. Interrelationships of alcohol consumption,
actions of alcohol and biochemical traits.
Pharmacol Biochem Behav 1980;
13: 297-302.
38. Finn D and Crabbe J. Chronic ethanol differentially alters susceptibility
to chemically-induced convulsions in Withdrawal Seizure-Prone and -Resistant
mice. J Pharmacol Exp Ther in press.
39. Gerlai R.
Molecular genetic analysis of mammalian behavior and brain processes:
caveats and perspectives. Sem Neurosci 1996; 8: 153-161.
40. Goate A and Edenberg J. The genetics of alcoholism. Curr
Opin Genet Dev 1998; 8: 282-286.
41. Goedde H, Agarwal D, Fritze G, Meier-Tackmann
D, Singh S, Beckmann G, Bhatia K, Chen L, Fang B, Lisker R et al.
Distribution of ADH2 and ALDH2 genotypes in different populations.
Hum Genet 1992; 88: 344-346.
42. Gora-Maslak G, McClearn G, Crabbe J, Phillips
T, Belknap J and Plomin R. Use of
recombinant inbred strains to identify quantitative trait loci in psychopharmacology.
Psychopharmacology 1991; 104: 413-424.
43. Grisel J, Belknap J, O'Toole L, Helms M, Wenger
C and Crabbe J. Quantitative trait
loci affecting methamphetamine responses in BSD recombinant inbred mouse strains.
J Neurosci 1997; 17: 745-754.
44. Harris R, McQuilkin S, Paylor R, Abeliovich
A, Tonegawa S and Wehner J. Mutant
mice lacking the g isoform of protein kinase C show decreased behavioral actions
of ethanol and altered function of g-aminobutyrate type-A receptors. Proc
Natl Acad Sci 1995; 92: 3658.
45. Harris R, Mihic S and Valenzuela C. Alcohol and benzodiazepines: Recent mechanistic
studies. Drug Alcohol Depend 1998; 51: 155-164.
46. Hitzemann B and Hitzemann R. Genetics, ethanol and the fos response: A comparison
of the C57BL/6J and DBA/2J inbred mouse strains. Alcohol
Clin Exp Res 1997; 21: 1497-1507.
47. Hitzemann R, Dains K, Bier-Langing C and Zahniser
N. On the selection of mice for haloperidol
response and nonresponse. Psychopharmacology
1991; 103: 244-250.
48. Hitzemann R, Qian Y and Hitzemann B. Dopamine and acetylcholine cell density in
the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines
of mice. J Pharmacol Exp Ther 1993; 266: 431-438.
49. Homanics G and Hiller-Sturmhofel S. New genetic technologies in alcohol research.
Alcohol Health Res World 1997; 21: 298-309.
50. Homanics G, Quinlan J, Mihalek R and Firestone
L. Alcohol and anesthetic mechanisms
in genetically engineered mice. Frontiers
in Bioscience 1998; 3: 548-558.
51. Johnson T, DeFries J and Markel P. Mapping quantitative trait loci for behavioral
traits in the mouse. Behav Genet 1992; 22: 635-653.
52. Jones A, Korpi E, McKernan R, Pelz R, Nusser
Z, Makela R, Mellor J, Pollard S, Bahn S, Stephenson F, Randall A, Sieghart
W, Somogyi P, Smith A and Wisden W. Ligand-gated
ion channel subunit partnerships: GABAA receptor a6 subunit gene inactivation
inhibits d subunit expression. J Neurosci 1997; 17: 1350-1362.
53. Keir W and Morrow A. Differential expression of GABAA receptor subunit
mRNAs in ethanol-naive withdrawal seizure resistant (WSR) vs prone (WSP) mouse
brain. Mol Brain Res 1994; 25: 200-208.
54. Lander E and Botstein D. Mapping Mendelian factors underlying quantitative
traits using RFLP linkage maps. Genetics
1989; 121: 185-199.
55. Lê A and Kiianmaa K. Characteristics of ethanol tolerance in alcohol
drinking (AA) and alcohol avoiding (ANA) rats. Psychopharmacology
1988; 94: 479-483.
56. Li T-K, Lumeng L and Doolittle D. Selective breeding for alcohol preference and
associated responses. Behav Genet 1993; 23: 163-170.
57. Maldonado R, Saiardi A, Valverde L, Samad T,
Roques B and Borrelli E. Absence of
opiate rewarding effects in mice lacking dopamine D2 receptors. Nature
1997; 388: 586-589.
58. Markel P, Shu P, Ebeling C, Carlson G, Nagle
D, Smutko J and Moore K. Theoretical
and empirical issues for marker-assisted breeding of congenic mouse strains. Nature
Genet 1997; 17: 280-284.
59. Marley R, Elmer G and Goldberg S. The use of pharmacogenetic techniques in drug
abuse research. Pharmacol Ther 1992; 53: 217-237.
60. McBride W, Chernet E, Russell R, Chamberlain
J, Lumeng L and Li T. Regional CNS
densities of serotonin and dopamine receptors in high alcohol-drinking (HAD)
and low alcohol-drinking (LAD) rats. Alcohol 1997; 14: 603-609.
61. McBride W and Li T-K. Animal models of alcoholism: Neurobiology of
high alcohol-drinking behavior in rodents.
Critical Reviews in Neurobiology
in press;
62. McBride W, Murphy J, Lumeng L and Li T-K. Serotonin, dopamine and GABA involvement in
alcohol drinking of selectively bred rats.
Alcohol 1990; 7: 199-205.
63. McClearn G and Kakihana R. Selective breeding for ethanol sensitivity:
Short-sleep and long-sleep mice. GE,
M, RA, D and VG, E, eds. Development of animal models as pharmacogenetic
tools. Washington: NIAAA Research
Monograph 6; 1981: 147-159.
64. Metten P and Crabbe J. Genetic determinants of severity of acute withdrawal
from diazepam in mice: Commonality with ethanol and pentobarbital. Pharmacol
Biochem Behav in press;
65. Mihic S, Ye Q, Wick M, Koltchine V, Krasowski
M, Finn S, Mascia M, Valenzuela C, Hanson K, Greenblatt E, Harris R and Harrison
N. Sites of alcohol and volatile anaesthetic
action on GABA(A) and glycine receptors. Nature
1997; 389: 385-389.
66. Miles M, Wilke N, Elliot M, Tanner W and Shah
S. Ethanol-responsive genes in neural
cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton
glucose-regulated protein (GRP94) molecular chaperones. Mol Pharmacol
1994; 46: 873-879.
67. Miyakawa T, Yagi T, Kitazawa H, Yasuda M, Kawai
N, Tsuboi K and Niki H. Fyn-kinase
as a determinant of ethanol sensitivity: relation to NMDA-receptor function.
Science 1997; 278: 698-701.
68. Overstreet D, Halikas J, Seredenin S, Kampov-Plevoy
A, Viglinskaya I, Kashevskaya O, Badishtov B, Knapp D, Mormède P, Kiianmaa
K, Li T-K and Rezvani A. Behavioral
similarities and differences among alcohol-preferring and -nonpreferring rats:
Confirmation by factor analysis and extension to additional groups.
Alcohol Clin Exp Res 1997; 21: 840-848.
69. Phillips T, Belknap J, Buck K and Cunningham
C. Genes on mouse chromosomes 2 and
9 determine variation in ethanol consumption.
Mammalian Genome in press.
70. Phillips T, Brown K, Burkhart-Kasch S, Wenger
C, Kelly M, Rubinstein M, Grandy D and Low M. Alcohol preference and sensitivity are reduced in mice lacking dopamine
D2 receptors. Nat Neurosci in press;
71. Piñeyro G, Castanon N, Hen R and Blier P.
Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus
of 5-HT1B knockout mice. NeuroReport
1995; 7: 353-359.
72. Risinger F, Bormann N and Oakes R. Reduced sensitivity to ethanol reward, but
not ethanol aversion, in mice lacking 5-HT1B receptors. Alcohol
Clin Exp Res 1996; 20: 1401-1405.
73. Rocha B, Scearce-Levie K, Lucas J, Hiroi N,
Castanon N, Crabbe J, Nestler E and Hen R.
Increased vulnerability to cocaine in mice lacking the serotonin-1B
receptor. Nature 1998; 393: 175-178.
74. Rubenstein M, Phillips T and Bunzow J. Mice lacking dopamine D4 receptors are supersensitive
to ethanol, cocaine, and methamphetamine. Cell
1997; 90: 991-1001.
75. Saudou F, Amara D, Dierich A, LeMeur M, Ramboz
S, Segu L, Buhot M and Hen R. Enhanced
aggressive behavior in mice lacking 5-HT1B receptor. Science
1994; 265: 1875-1878.
76. Schafer G, Crabbe J and Wiren K. Identification of neuroendocrine-specific protein
as an ethanol-regulated gene using mRNA differential display. Mammalian
Genome in press.
77. Schuckit M.
Low level of response to alcohol as a predictor of future alcoholism.
Am J Psychiat 1994; 151: 184-189.
78. Shuster L.
Pharmacogenetics of drugs of abuse.
Ann NY Acad Sci 1989; 562:
56-73.
79. Spuhler K and Deitrich R. Correlative analysis of ethanol-related phenotypes
in rat inbred strains. Alcohol Clin Exp Res 1984; 8: 480-484.
80. Stewart R, Murphy J, McBride W, lumeng L and
Li T. Place conditioning with alcohol
in alcohol-preferring and -nonpreferring rats.
Pharmacol Biochem Behav 1996;
53: 487-491.
81. Thiele T, Marsh D, St. Marie L, Bernstein I
and Palmiter R. Ethanol consumption
and resistance are inversely related to neuropeptide Y levels. Nature
1998; 396: 366-369.
82. Thiele T, van Dijk G and Bernstein I. Ethanol-induced c-Fos expression in rat lines
selected for low and high alcohol consumption. Brain Res 1997; 756: 278-282.
83. Trillat A, Malagie I, Scearce K, Pons D, Anmella
M, Jacquot C, Hen R and Gardier A. Regulation
of serotonin release in the frontal cortex and ventral hippocampus of homozygous
mice lacking 5-HT1B receptors: in vivo microdialysis studies.
J Neurochem 1997; 69: 2019-2025.
84. Uhl G, Elmer G, LaBuda M and Pickens R. Genetic influences in drug abuse. Bloom F and Kupfer D, eds. Psychopharmacology: The fourth generation of progress. New York: Raven Press; 1995: 1793-1806.
85. Wafford K, Burnett D, Harris R and Whiting
P. GABAA receptor subunit expression
and sensitivity to ethanol. Alc Alcoholism 1993; 2: 327.
86. Wehner J and Bowers B. Use of transgenics, null mutants, and antisense
approaches to study ethanol's actions. Alcohol Clin Exp Res 1995;
19: 811-820.
87. Xu M, Koeltzow T, Santiago G, Moratalla R,
Cooper D, Hu X, White N, Graybiel A, White F and Tonegawa S. Dopamine D3 receptor mutant mice exhibit increased
behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.
Neuron 1997; 19: 837-848.
88. Zahniser N, Buck K, Curella P, McQuilkin S,
Wilson-Shaw D, Miller C and Klein R. GABAA
receptor function and regional analysis of subunit mRNAs in long-sleep and
short-sleep mouse brain. Mol
Brain Res 1992; 14: 196-206.
89. Zhou R, McKinzie D, Patel T, Lumeng L and Li T. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats. Alcohol Clin Exp Res 1998; 22: 266-269.